Cablegate: Response to Fda Regarding U.S./Fda Orphan Product
PP RUEHAG RUEHDF RUEHLZ
DE RUEHMZ #0563 2770937
ZNR UUUUU ZZH
P 040937Z OCT 07
FM AMCONSUL MUNICH
TO RUEHC/SECSTATE WASHDC PRIORITY 4142
UNCLAS MUNICH 000563
STATE PLEASE PASS TO FDA OFFICE OF INTERNATIONAL PROGRAMS - ELAINE
E.O. 12958: N/A
TAGS: KSCA TBIO OTRA TPHY US GM
SUBJECT: RESPONSE TO FDA REGARDING U.S./FDA ORPHAN PRODUCT
DEVELOPMENT GRANT AWARD FDA-936-07
REF: SECSTATE 133848
1. Consulate General Munich is unaware of any information that
would present negative foreign policy implications in connection
with awarding a product development grant award to either the
Medizinische Universitatsklinik Wurzburg or the Klinikum der
Universitat Munchen, and thus has no objections to awarding a grant
to either institution.
2. This report has been coordinated with Embassy Berlin.
3. Previous reporting from Munich is available on our SIPRNET
website at www.state.sgov.gov/p/eur/munich/ .